While pharma groans at the endless stream of layoffs, one headhunting firm has some encouraging news: Pharma might be cutting costs, but it's also hiring.
This year, hundreds of pharma employees have found themselves on the chopping block, and there seems to be no end in sight to the layoffs. However, one employment-consulting firm took a closer look at where displaced pharma workers are ending up, and the results were actually positive.
According to Lynn Brown, marketing vice president for Right Management, many of the industry's laid off workers are finding jobs at other pharma companies, or in jobs related to the industry, such as contract sales, research organizations, or the biotech sector.Between January 2007 and March 2008, Right Management interviewed 1,282 pharma employees who were displaced from their jobs, and found that:
Data was taken from satisfaction surveys completed by Right Management's clients; the firm did not break down the survey by job title or segment, so it's uncertain how many positions were sales, research and development, or executive level. But according to Brown, much of the downsizing comes from strategic change.
"One of the big things we find in the pharma industry is that when a company announces they're downsizing, other pharmas call us right away to say, 'If you are servicing the out-placing work for X company, could you make those candidates available to us, or set up a job fair'" said Brown.
Brown also noted that the number of former pharma employees reaching out for assistance is no bigger this year than in the last couple of years, but she said that the number of layoffs are expected to increase in the next few years. Pharma compares to the financial segment, which Right Management also covers. Both verticals have seen a major crunch in the last year, but employees in both fields are landing jobs in the same industry.
"These numbers are strong," Brown said. "It shows that people do find jobs pretty easily in pharma."
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.